{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,11,19]],"date-time":"2024-11-19T19:02:17Z","timestamp":1732042937358},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"8","license":[{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T00:00:00Z","timestamp":1692230400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"name":"Universit\u00e4tsklinikum Freiburg"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["HNO"],"published-print":{"date-parts":[[2024,8]]},"abstract":"<jats:title>Zusammenfassung<\/jats:title><jats:sec>\n                <jats:title>Hintergrund<\/jats:title>\n                <jats:p>Das aktive transkutane, teilimplantierbare, osseointegrierte Knochenleitungssystem Cochlear\u2122 Osia\u00ae (Fa.\u00a0Cochlear, Sydney, Australien) ist seit April 2021 im deutschsprachigen Raum zugelassen. Das Osia ist f\u00fcr Patienten mit Schallleitungs- (SL-SH) oder kombinierter Schwerh\u00f6rigkeit (komb-SH) mit einem mittleren Knochenleitungsh\u00f6rverlust von maximal 55\u202fdB HL oder bei einseitiger Taubheit (\u201esingle-sided deafness\u201c, SSD) indiziert.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ziel der Arbeit<\/jats:title>\n                <jats:p>Ziel dieser retrospektiven Untersuchung war es, die Pr\u00e4diktion des postoperativen Sprachverstehens mit Osia zu untersuchen sowie die Ergebnisse des Sprachverstehens von Patienten mit komb-SH und einem geringen Dynamikbereich von weniger als 30\u202fdB nach erfolgter Osia-Versorgung zu evaluieren.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Material und Methoden<\/jats:title>\n                <jats:p>Zwischen 2017 and 2022 wurden 29\u00a0erwachsene Patienten mit dem Osia versorgt, davon 10\u00a0Patienten (11\u00a0Ohren) mit SL-SH und 19\u00a0Patienten (25\u00a0Ohren) mit komb-SH. Die Patienten mit komb-SH wurden in 2\u00a0Gruppen aufgeteilt: komb-SH\u2011I mit \u00fcber 4\u00a0Frequenzen gemittelter H\u00f6rschwelle in Knochenleitung (\u201efour-frequency pure-tone average\u201c,(PTA4-KL)) \u2265\u202f20\u202fdB HL und &lt;\u202f40\u202fdB HL (<jats:italic>n<\/jats:italic>\u202f=\u200915\u00a0Patienten, 20\u00a0Ohren) vs. komb-SH-II mit PTA4-KL \u2265\u202f40\u202fdB HL (<jats:italic>n<\/jats:italic>\u202f=\u20094\u00a0Patienten, 5\u00a0Ohren). Alle Patienten testeten pr\u00e4operativ ein Knochenleitungsger\u00e4t am Softband. Pr\u00e4operativ wurde das Sprachverstehen im Freiburger Einsilbertest unversorgt und mit Testsystem erfasst. Das maximale Einsilberverstehen (mEV) unversorgt und das Einsilberverstehen (EV) mit Testsystem bei 65\u202fdB SPL wurde mit dem postoperativ erreichten EV mit Osia bei 65\u202fdB SPL korreliert.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Ergebnisse<\/jats:title>\n                <jats:p>Die pr\u00e4operative Vorhersage f\u00fcr das postoperative Ergebnis mit Osia war anhand des mEV mit h\u00f6herer Varianzaufkl\u00e4rung als mit dem EV bei 65\u202fdB SPL mit KL-Testger\u00e4t am Softband m\u00f6glich. Das postoperative EV war am besten f\u00fcr die Patienten mit SL-SH und am schlechtesten f\u00fcr Patienten mit komb-SH mit einer PTA4-KL \u2265\u202f40\u202fdB HL vorhersagbar. Die Ergebnisse mit dem Testger\u00e4t am Softband zeigen eher das minimal erreichbare Ergebnis und das mEV eher das realistisch zu erreichende Ergebnis mit Osia.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Schlussfolgerung<\/jats:title>\n                <jats:p>Das Osia kann f\u00fcr die Versorgung von SL-SH und komb-SH unter Beachtung der Indikationsgrenzen eingesetzt werden. Auch die mittlere pr\u00e4operative Knochenleitungsh\u00f6rschwelle liefert n\u00e4herungsweise eine Absch\u00e4tzung des postoperativen EV mit Osia, f\u00fcr das die genaueste Vorhersage anhand des pr\u00e4operativen mEV erzielt wird. Die Vorhersagegenauigkeit reduziert sich ab einer PTA4-KL von \u2265\u202f40\u202fdB.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s00106-023-01336-4","type":"journal-article","created":{"date-parts":[[2023,8,17]],"date-time":"2023-08-17T15:02:18Z","timestamp":1692284538000},"page":"537-546","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vorhersage des postoperativen Sprachverstehens mit dem transkutanen teilimplantierbaren Knochenleitungsh\u00f6rsystem Osia\u00ae","Prediction of speech understanding with the transcutaneous partially implantable bone conduction hearing system Osia\u00ae. German Version"],"prefix":"10.1007","volume":"72","author":[{"given":"Susan","family":"Arndt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Wesarg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Antje","family":"Aschendorff","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iva","family":"Speck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Hocke","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till Fabian","family":"Jakob","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ann-Kathrin","family":"Rauch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2023,8,17]]},"reference":[{"issue":"21","key":"1336_CR1","doi-asserted-by":"publisher","first-page":"34155570","DOI":"10.1007\/s00405-021-06946-8","volume":"2021","author":"S Arndt","year":"2021","unstructured":"Arndt\u00a0S, Rauch\u00a0AK, Speck\u00a0I (2021) Active transcutaneous bone-anchored hearing implant: how I do it. Eur Arch Otorhinolaryngol 2021(21):34155570. https:\/\/doi.org\/10.1007\/s00405-021-06946-8","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"1","key":"1336_CR2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1007\/s00106-019-00780-5","volume":"68","author":"C D\u00f6rfler","year":"2020","unstructured":"D\u00f6rfler\u00a0C, Hocke\u00a0T, Hast\u00a0A, Hoppe\u00a0U (2020) Speech recognition with hearing aids for 10 standard audiograms. HNO 68(1):40\u201347","journal-title":"HNO"},{"key":"1336_CR3","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1007\/s00106-007-1608-7","volume":"56","author":"I Gr\u00fcnder","year":"2008","unstructured":"Gr\u00fcnder\u00a0I, Seidl\u00a0R, Ernst\u00a0A et al (2008) Wertigkeit der BAHA-Testung f\u00fcr das postoperative H\u00f6rergebnis. HNO 56:1020\u20131024. https:\/\/doi.org\/10.1007\/s00106-007-1608-7","journal-title":"HNO"},{"key":"1336_CR4","doi-asserted-by":"publisher","first-page":"443","DOI":"10.1007\/s00106-013-2813-1","volume":"62","author":"U Hoppe","year":"2014","unstructured":"Hoppe\u00a0U, Hast\u00a0A, Hocke\u00a0T (2014) Sprachverstehen mit H\u00f6rgeraten in Abh\u00e4ngigkeit vom Tongeh\u00f6r. HNO 62:443\u2013448","journal-title":"HNO"},{"issue":"6","key":"1336_CR5","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1097\/MAO.0000000000000730","volume":"36","author":"U Hoppe","year":"2015","unstructured":"Hoppe\u00a0U, Hast\u00a0A, Hocke\u00a0T (2015) Audiometry-Based Screening Procedure for Cochlear Implant Candidacy. Otol Neurotol 36(6):1001\u20131005","journal-title":"Otol Neurotol"},{"issue":"3","key":"1336_CR6","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1007\/s00106-018-0605-3","volume":"67","author":"U Hoppe","year":"2019","unstructured":"Hoppe\u00a0U, Hocke\u00a0T, Hast\u00a0A, Iro\u00a0H (2019) Das maximale Einsilberverstehen als Pr\u00e4diktor f\u00fcr das Sprachverstehen mit Cochleaimplantat. HNO 67(3):199\u2013206. https:\/\/doi.org\/10.1007\/s00106-018-0605-3","journal-title":"HNO"},{"key":"1336_CR7","doi-asserted-by":"publisher","DOI":"10.3389\/fnins.2021.762337","author":"J Liu","year":"2021","unstructured":"Liu J, Huang X, Zhang J (2021) Unilateral Conductive Hearing Loss Disrupts the Developmental Refinement of Binaural Processing in the Rat Primary Auditory Cortex. Front Neurosci.  https:\/\/doi.org\/10.3389\/fnins.2021.762337","journal-title":"Front Neurosci"},{"issue":"9","key":"1336_CR8","doi-asserted-by":"publisher","first-page":"1147","DOI":"10.1097\/MAO.0000000000001954","volume":"39","author":"H Maier","year":"2018","unstructured":"Maier\u00a0H, Lenarz\u00a0T, Dollezal\u00a0LV, Busch\u00a0S (2018) Direct acoustic cochlear implants lead to an improved speech perception gap compared to conventional hearing aid. Otol Neurotol 39(9):1147\u20131152","journal-title":"Otol Neurotol"},{"issue":"6","key":"1336_CR9","doi-asserted-by":"publisher","first-page":"809","DOI":"10.1097\/MAO.0000000000001412","volume":"38","author":"A Muller","year":"2017","unstructured":"Muller\u00a0A, Mir-Salim\u00a0P, Zellhuber\u00a0N, Helbig\u00a0R, Bloching\u00a0M, Schmidt\u00a0T, Koscielny\u00a0S, Dziemba\u00a0OC, Plontke\u00a0SK, Rahne\u00a0T (2017) Influence of floating-mass transducer coupling efficiency for active middle-ear implants on speech recognition. Otol Neurotol 38(6):809\u2013814","journal-title":"Otol Neurotol"},{"issue":"9","key":"1336_CR10","doi-asserted-by":"publisher","first-page":"1249","DOI":"10.1097\/MAO.0000000000002794","volume":"41","author":"EAM Mylanus","year":"2020","unstructured":"Mylanus\u00a0EAM, Hua\u00a0H, Wigren\u00a0S, Arndt\u00a0S, Skarzynski\u00a0PH, Telian\u00a0SA, Briggs\u00a0RJS (2020) Multicenter clinical investigation of a\u00a0new active Osseointegrated steady-state implant system. Otol Neurotol 41(9):1249\u20131257. https:\/\/doi.org\/10.1097\/MAO.0000000000002794","journal-title":"Otol Neurotol"},{"issue":"3","key":"1336_CR11","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1001\/archotol.124.3.271","volume":"124","author":"EAM Mylanus","year":"1998","unstructured":"Mylanus\u00a0EAM, van der Pouw\u00a0KC, Snik\u00a0AF, Cremers\u00a0CW (1998) Intraindividual comparison of the bone-anchored hearing aid and air-conduction hearing aids. Arch Otolaryngol Head Neck Surg 124(3):271\u2013276","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"1336_CR12","unstructured":"Osia 2 System Datasheet. D1618102. Cochlear Bone Anchored Solutions AB."},{"issue":"6","key":"1336_CR13","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1007\/s00106-019-00776-1","volume":"69","author":"T Rahne","year":"2021","unstructured":"Rahne\u00a0T (2021) Physical audiological principles of implantable hearing systems: About power transmission, coupling and power output. HNO 69(6):475\u2013482","journal-title":"HNO"},{"key":"1336_CR14","doi-asserted-by":"publisher","first-page":"108424","DOI":"10.1016\/j.heares.2021.108424","volume":"421","author":"T Rahne","year":"2022","unstructured":"Rahne\u00a0T, Plontke\u00a0SK (2022) Systematic and audiological indication criteria for bone conduction devices and active middle ear implants. Hear Res 421:108424","journal-title":"Hear Res"},{"issue":"9","key":"1336_CR15","doi-asserted-by":"publisher","first-page":"4279","DOI":"10.1007\/s00405-021-07167-9","volume":"279","author":"AK Rauch","year":"2022","unstructured":"Rauch\u00a0AK, Wesarg\u00a0T, Aschendorff\u00a0A, Speck\u00a0I, Arndt\u00a0S (2022) Long-term data of the new transcutaneous partially implantable bone conduction hearing system Osia. Eur Arch Otorhinolaryngol 279(9):4279\u20134288. https:\/\/doi.org\/10.1007\/s00405-021-07167-9","journal-title":"Eur Arch Otorhinolaryngol"},{"issue":"79\u201393","key":"1336_CR16","doi-asserted-by":"publisher","first-page":"39691","DOI":"10.2147\/MDER","volume":"8","author":"S Reinfeldt","year":"2015","unstructured":"Reinfeldt\u00a0S, H\u00e5kansson\u00a0B, Taghavi\u00a0H, Eeg-Olofsson\u00a0M (2015) New developments in bone conduction hearing implants: a\u00a0review. Med Devices 8(79\u201393):39691. https:\/\/doi.org\/10.2147\/MDER","journal-title":"Med Devices"},{"key":"1336_CR17","unstructured":"Richtlinie des Gemeinsamen Bundesausschusses uber die Verordnung von Hilfsmitteln in der vertrags\u00e4rztlichen Versorgung (Hilfsmittel-Richtlinie\/HilfsM-RL) in Kraft getreten am 17.\u00a0February 2017."},{"key":"1336_CR18","unstructured":"S2k-Leitlinie Cochlea-Implantat Versorgung (AWMF); Version: 3.0 ; Stand: 31. Okt. 2020 ; G\u00fcltig bis: 30. Okt. 2025 (in \u00dcberarbeitung)"},{"issue":"Suppl","key":"1336_CR19","first-page":"1","volume":"12","author":"AF Snik","year":"2005","unstructured":"Snik\u00a0AF, Mylanus\u00a0EA, Proops\u00a0DW, Wolfaardt\u00a0JF, Hodgetts\u00a0WE, Somers\u00a0T, Niparko\u00a0JK, Wazen\u00a0JJ, Sterkers\u00a0O, Cremers\u00a0CW, Tjellstr\u00f6m\u00a0A (2005) Consensus statements on the BAHA system: where do we stand at present? Ann Otol Rhinol Laryngol 12(Suppl):1\u201312","journal-title":"Ann Otol Rhinol Laryngol"},{"issue":"8","key":"1336_CR20","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1007\/s00106-016-0166-2","volume":"64","author":"A Winkler","year":"2016","unstructured":"Winkler\u00a0A, Holube\u00a0I (2016) Test-retest reliability of the Freiburg monosyllabic speech test. HNO 64(8):564\u2013571","journal-title":"HNO"},{"key":"1336_CR21","doi-asserted-by":"publisher","first-page":"102819","DOI":"10.1016\/j.nicl.2021.102819","volume":"32","author":"T Yang","year":"2021","unstructured":"Yang\u00a0T, Liu\u00a0Q, Fan\u00a0X, Hou\u00a0B, Wang\u00a0J, Chen\u00a0X (2021) Altered regional activity and connectivity of functional brain networks in congenital unilateral conductive hearing loss. Neuroimage Clin 32:102819","journal-title":"Neuroimage Clin"}],"container-title":["HNO"],"original-title":[],"language":"de","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-023-01336-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00106-023-01336-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00106-023-01336-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T15:07:35Z","timestamp":1721747255000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00106-023-01336-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8,17]]},"references-count":21,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["1336"],"URL":"https:\/\/doi.org\/10.1007\/s00106-023-01336-4","relation":{},"ISSN":["0017-6192","1433-0458"],"issn-type":[{"value":"0017-6192","type":"print"},{"value":"1433-0458","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,8,17]]},"assertion":[{"value":"14 May 2023","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 August 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Einhaltung ethischer Richtlinien"}},{"value":"S.\u00a0Arndt gibt Folgendes an: Advanced Bionics: Reisekostenerstattung, finanzielle Unterst\u00fctzung f\u00fcr Forschung; Cochlear: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Reisekostenerstattung; MED-EL: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Reisekostenerstattung; Oticon Medical: Reisekostenerstattung, finanzielle Unterst\u00fctzung f\u00fcr Forschung. T.\u00a0Wesarg gibt Folgendes an: Advanced Bionics: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Reisekostenerstattung; Cochlear: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Reisekostenerstattung; MED-EL: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Reisekostenerstattung. A.\u00a0Aschendorff gibt Folgendes an: Advanced Bionics: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Medical advisory board, Reisekostenerstattung; Cochlear: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Reisekostenerstattung; MED-EL: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Reisekostenerstattung; Oticon Medical: finanzielle Unterst\u00fctzung f\u00fcr Forschung, Reisekostenerstattung. I.\u00a0Speck gibt Folgendes an: Cochlear: Reisekostenerstattung. T.\u00a0Hocke ist Mitarbeiter von Cochlear Deutschland. T.F.\u00a0Jakob und A.-K.\u00a0Rauch geben an, dass kein Interessenkonflikt besteht.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}},{"value":"Die vorliegende Studie wurde mit Zustimmung der Ethik-Kommission der Universit\u00e4t Freiburg (Nr. 21\/1142) im Einklang mit nationalem Recht sowie gem\u00e4\u00df der Deklaration von Helsinki von 2013 (in der aktuellen, \u00fcberarbeiteten Fassung) durchgef\u00fchrt (DRKS 00024640).","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Interessenkonflikt"}}]}}